Project Grant HT94252510959
Award Date 8/15/25
Completion Date 8/14/28
Dollars Obligated $780K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- Oregon Health & Science University was awarded a $506,554 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. Through basic, applied, and advanced biomedical research supported by this program, the Army aims to transform military and public health care by...
- The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
- Oregon Health & Science University was awarded a $385,000 project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The two-year grant will support research to investigate the molecular and biological contributions of the SMARCA4 tumor suppressor gene to the formation of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Through basic and applied medical research, the Military Medical Research and Development...
- This federal Project Grant award of $1,525,292 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project led by Oregon Health & Science University (OHSU) to characterize the progression of prostate cancer through integrated analysis of single-cell data. The project, which commenced on September 30, 2024 and is scheduled for completion by September 29, 2027, aims to advance the understanding of prostate cancer biology and...
- This Project Grant award of $1,401,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The funding will support a 3-year research project investigating the impact of recent childbirth on breast cancer prognosis and tumor molecular phenotypes among young Black and White women. The research aims to enhance understanding of breast cancer disease progression and outcomes in this...
- This Project Grant award of $623,953 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Oregon Health & Science University to develop an improved and safer chemotherapy for medulloblastoma, a type of brain cancer, using a self-assembled nanomaterial. The research aims to transform healthcare for military service members, veterans, and the general public by advancing innovative medical solutions. The award has a...
- The Project Grant award for $897,448.00, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports Oregon Health & Science University's development of "NEXT-GENERATION ELQS FOR LONG-TERM PROTECTION AGAINST MALARIA." This research initiative aims to advance novel treatments and protective measures against malaria, a key focus area for the Defense Health Agency's military medical research initiatives....
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $999,823 Project Grant to Oregon Health & Science University (OHSU) on June 1, 2024. The grant, titled "TARGETING NEURODEGENERATION IN THE AGED DEMYELINATED CNS," supports OHSU's biomedical research efforts to investigate innovative treatments for neurological disorders. Through this funding, OHSU will conduct basic, applied, and advanced research to develop new medical...
- This Project Grant award, valued at $590,625.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of California, Los Angeles (UCLA) for a pilot study on dual immunotherapy in combination with chemotherapy for patients with pancreatic adenocarcinoma. The award, with a period of performance from September 1, 2025 to August 31, 2028, will support research to investigate the immune mechanisms of resistance to this...